Life style risks of Parkinson's disease: association between decreased water intake and constipation - PubMed (original) (raw)
Life style risks of Parkinson's disease: association between decreased water intake and constipation
Akira Ueki et al. J Neurol. 2004 Oct.
Abstract
Gastrointestinal dysfunction, especially constipation, is one of the major problems in the daily life of patients with Parkinson's disease (PD). About 60 to 80% of PD patients suffer from constipation. Several studies have proven that constipation appears about 10 to 20 years prior to motor symptoms. More recently, Abbott et al. have found from a large scale prospective study that lower frequency bowel movements predict the future risk of PD. Furthermore, Braak et al. have found that Lewy neuritis and Lewy bodies, the hallmarks of PD pathology, appear in the dorsal nucleus of vagus in the earliest stage of the disease and then extend upward through the brain stem to reach the substantia nigra in the third stage. They also hypothesize that some yet undefined toxins break through the mucosal barrier of the intestine and are incorporated into the axon terminal of the vagus nerve and transported in a retrograde manner to the vagus nucleus. In this study, we assessed bowel movements and nutritional status in Japanese patients with PD. We found that intake of water was significantly decreased in PD patients from early life and associated with their constipation. Ninety four patients with PD (M 50, F 44) were enrolled. Nutritional status was assessed using the Self-administered Diet History Questionnaire (DHQ). Total water intake was calculated from the consumption of coffee, green tea, and tea. We also questioned the behavior of water drinking from the early stage of life. The questionnaire for bowel movements concerned the frequency of defecation, age of onset of constipation, and age of onset of motor dysfunction. Less than one bowel movement in 3 days was defined as constipation. The nutritional status of PD patients did not differ significantly from those of controls though several studies have shown excess intake of animal fats or reduced consumption of coffee are risks in PD. In contrast, water intake was significantly lower in PD patients than controls (604.0+/-377.2 ml/d vs 909.5+/-531.6 ml/d; P<0.0001). Interestingly, PD patients tended not to feel thirsty and thus they had no desire to drink water throughout their life. Seventy four patients out of 94 (78.7 %) complained of constipation. Mean bowel frequency was once per 3.3+/-1.1 days and 71.1% of patients were defined as having constipation. Women suffered from constipation more frequently than men (82.4% vs 61.9 %). In 33 patients out of 74 (44.6 %), onset of constipation preceded motor disturbance by an average time of 18.1+/-18.8 years. Furthermore, the amount of water intake correlated inversely with the severity of constipation and the depletion of water intake preceded constipation in most cases. The present results support previous findings that constipation precedes the onset of motor dysfunction in PD. To our knowledge, this is the first report to point out latent water depletion in PD patients. It is not certain at present whether coffee or caffeine themselves are the protective factor for PD or alternatively the amount of water in coffee drinking is more essential. Prospective studies on a large scale are necessary to elucidate the real meaning of water depletion in PD.
Similar articles
- Frequency of bowel movements and the future risk of Parkinson's disease.
Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Abbott RD, et al. Neurology. 2001 Aug 14;57(3):456-62. doi: 10.1212/wnl.57.3.456. Neurology. 2001. PMID: 11502913 - Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.
Abbott RD, Ross GW, White LR, Sanderson WT, Burchfiel CM, Kashon M, Sharp DS, Masaki KH, Curb JD, Petrovitch H. Abbott RD, et al. J Neurol. 2003 Oct;250 Suppl 3:III30-9. doi: 10.1007/s00415-003-1306-7. J Neurol. 2003. PMID: 14579122 - More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
Mertsalmi TH, Aho VTE, Pereira PAB, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Mertsalmi TH, et al. Eur J Neurol. 2017 Nov;24(11):1375-1383. doi: 10.1111/ene.13398. Epub 2017 Sep 11. Eur J Neurol. 2017. PMID: 28891262 - A survey of subjective constipation in Parkinson's disease patients in shanghai and literature review.
Gan J, Wan Y, Shi J, Zhou M, Lou Z, Liu Z. Gan J, et al. BMC Neurol. 2018 Mar 15;18(1):29. doi: 10.1186/s12883-018-1034-3. BMC Neurol. 2018. PMID: 29544459 Free PMC article. Review. - Constipation: an emerging risk factor for Parkinson's disease?
Stirpe P, Hoffman M, Badiali D, Colosimo C. Stirpe P, et al. Eur J Neurol. 2016 Nov;23(11):1606-1613. doi: 10.1111/ene.13082. Epub 2016 Jul 22. Eur J Neurol. 2016. PMID: 27444575 Review.
Cited by
- Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort.
Kenna JE, Bakeberg MC, Gorecki AM, Chin Yen Tay A, Winter S, Mastaglia FL, Anderton RS. Kenna JE, et al. Mov Disord Clin Pract. 2021 Jan 5;8(2):245-253. doi: 10.1002/mdc3.13134. eCollection 2021 Feb. Mov Disord Clin Pract. 2021. PMID: 33553495 Free PMC article. - Risk of premotor symptoms in patients with newly diagnosed PD: a nationwide, population-based, case-control study in Taiwan.
Wu YH, Liao YC, Chen YH, Chang MH, Lin CH. Wu YH, et al. PLoS One. 2015 Jun 24;10(6):e0130282. doi: 10.1371/journal.pone.0130282. eCollection 2015. PLoS One. 2015. PMID: 26107935 Free PMC article. - Sudden unexpected death in Parkinson's disease: Insights from clinical practice.
Scorza FA, Guimarães-Marques M, Nejm M, de Almeida ACG, Scorza CA, Fiorini AC, Finsterer J. Scorza FA, et al. Clinics (Sao Paulo). 2022 Feb 10;77:100001. doi: 10.1016/j.clinsp.2021.100001. eCollection 2022. Clinics (Sao Paulo). 2022. PMID: 35152167 Free PMC article. Review. - Midlife milk consumption and substantia nigra neuron density at death.
Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM. Abbott RD, et al. Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658906 Free PMC article. - Micronutrients and Risk of Parkinson's Disease: A Systematic Review.
Sherzai AZ, Tagliati M, Park K, Gatto NM, Pezeshkian S, Sherzai D. Sherzai AZ, et al. Gerontol Geriatr Med. 2016 Apr 22;2:2333721416644286. doi: 10.1177/2333721416644286. eCollection 2016 Jan-Dec. Gerontol Geriatr Med. 2016. PMID: 28138496 Free PMC article.
References
- Neurology. 1996 Sep;47(3):636-43 - PubMed
- Eur Neurol. 1992;32(3):134-40 - PubMed
- Neurology. 1992 Apr;42(4):726-32 - PubMed
- Lancet. 1995 Sep 30;346(8979):861-4 - PubMed
- J Neuropathol Exp Neurol. 2002 May;61(5):413-26 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical